1.Effects of HPMCAS MF on absorption of silybin from supersaturable self-nanoemulsifying drug delivery system.
Zhang-Ting LAI ; Hai-Bo DING ; Qie-Ying JIANG ; Qi-Li YUAN ; Zheng-Gen LIAO
China Journal of Chinese Materia Medica 2021;46(5):1120-1127
To evaluate the effects of Hydroxypropyl methylcellulose acetate succinate(HPMCAS MF) on absorption of silybin(SLB) from supersaturable self-nanoemulsifying drug delivery system which was pre-prepared at the early stage experiment. The cell toxicity of self-emulsifying preparation was evaluated by the MTT method, and the in vitro membrane permeability and absorption promoting effect of the self-emulsifying preparation were evaluated by establishing a Caco-2 cell monolayer model. The in vivo and in vitro supersaturation correlation was evaluated via the blood concentration of SLB. The results of MTT showed that the concentration of the preparation below 2 mg·mL~(-1)(C_(SLB) 100 μg·mL~(-1)) was not toxic to Caco-2 cells, and the addition of polymer had no significant effect on Caco-2 cells viability. As compared with the solution group, the transport results showed that the P_(app)(AP→BL) of the self-emulsifying preparation had a very significant increase; the transport rate of silybin can be reduced by polymer in 0-30 min; however, there was no difference in supersaturated transport between supersaturated SLB self-nanoemulsion drug delivery system(SLB-SSNEDDS) and SLB self-nanoemulsion drug delivery system(SLB-SNEDDS) within 2 hours. As compared with SLB suspension, pharmacokinetic parameters showed that the blood concentration of both SLB-SNEDDS and SLB-SSNEDDS groups were significantly increased, and C_(max) was 5.25 times and 9.69 times respectively of that in SLB suspension group, with a relative bioavailability of 578.45% and 1 139.44% respectively. C_(max) and relative bioavailability of SLB-SSNEDDS were 1.85 times and 197% of those of SLB-SNEDDS, respectively. Therefore, on the one hand, SSNEDDS can increase the solubility of SLB in gastrointestinal tract by maintaining stability of SLB supersaturation state; on the other hand, the osmotic transport process of SLB was regulated through the composition of its preparations, and both of them could jointly promote the transport and absorption of SLB to improve the oral bioavailability of SLB.
Administration, Oral
;
Biological Availability
;
Caco-2 Cells
;
Drug Delivery Systems
;
Emulsions
;
Humans
;
Methylcellulose/analogs & derivatives*
;
Nanoparticles
;
Particle Size
;
Silybin
;
Solubility
2.Co-amorphous technology to improve dissolution and physical stability of silybin.
Huan LIU ; Guo-Wei ZHAO ; Qie-Ying JIANG ; Xin-Li LIANG ; Liao-Qi OUYANG ; Hai-Bo DING ; Xu-Long CHEN ; Zheng-Gen LIAO
China Journal of Chinese Materia Medica 2022;47(1):103-110
The present study explored the effect of co-amorphous technology in improving the dissolution rate and stability of silybin based on the puerarin-silybin co-amorphous system prepared by the spray-drying method. Solid-state characterization was carried out by powder X-ray diffraction(PXRD), polarizing microscopy(PLM), Fourier transform infrared spectroscopy(FT-IR), differential scanning calorimetry(DSC), etc. Saturated powder dissolution, intrinsic dissolution rate, moisture absorption, and stability were further investigated. The results showed that puerarin and silybin formed a co-amorphous system at a single glass transition temperature which was higher than that of any crude drug. The intrinsic dissolution rate and supersaturated powder dissolution of silybin in the co-amorphous system were higher than those of the crude drug and amorphous system. The co-amorphous system kept stable for as long as three months under the condition of 40 ℃, 75% relative humidity, which was longer than that of the single amorphous silybin. Therefore, the co-amorphous technology could significantly improve the dissolution and stability of silybin.
Calorimetry, Differential Scanning
;
Desiccation
;
Drug Compounding/methods*
;
Drug Stability
;
Silybin
;
Solubility
;
Spectroscopy, Fourier Transform Infrared
;
Technology
;
X-Ray Diffraction
3.Silibinin alleviates N-nitrosodimethylamine-induced glutathione dysregulation and hepatotoxicity in rats.
Devaraj EZHILARASAN ; Sivanesan KARTHIKEYAN
Chinese Journal of Natural Medicines (English Ed.) 2016;14(1):40-47
The present study was designed to evaluate the hepatoprotective and antioxidant potentials of silibinin (SBN) against N-nitrosodimethylamine (DMN)-induced toxic insults in the rat liver. The liver damage was induced in Wistar albino rats by repeated administration of DMN (10 mg·kg(-1) b.w., i.p.) on 3 consecutive days per week for 3 weeks. SBN (100 mg·kg(-1) b.w., p.o.) was given daily to the DMN treated rats for two weeks. The marker enzymes of liver toxicity and second-line enzymic and non-enzymic antioxidants were evaluated in serum and liver tissues before and after SBN treatment. Histopathology of the liver was evaluated by H & E staining. The DMN treatment produced a progressive increase in all the serum marker enzymes (AST, ALT, ALP, LDH, and γ-GT), peaking on Day 21. This treatment produced highly significant decreases in all the second-line antioxidant parameters (GSH, GST, GR, GPx, and vitamins C and E). The SBN treatment significantly reversed the DMN-induced damages, towards normalcy. Histopathological studies confirmed the development of liver toxicity in DMN-treated rats, which was reversed by SBN treatment in corroboration with the aforementioned biochemical results, indicating the hepatoprotective and antioxidant properties of SBN. In conclusion, the DMN-induced degenerative changes in the liver were alleviated by SBN treatment and this protective ability may be attributed to its antioxidant, free radical scavenging, and membrane stabilizing properties.
Animals
;
Antioxidants
;
pharmacology
;
Chemical and Drug Induced Liver Injury
;
drug therapy
;
Dimethylnitrosamine
;
toxicity
;
Female
;
Glutathione
;
metabolism
;
Male
;
Protective Agents
;
pharmacology
;
Rats
;
Rats, Wistar
;
Silybin
;
Silymarin
;
pharmacology
4.Effects of Platycodonis Radix-Curcumae Rhizoma on oral nanoparticle uptake and in vitro inhibition against breast cancer metastasis.
Jiang-Pei SHI ; Rong-Guang ZHANG ; Xiao-Yan GU ; Ying-Wei SUN ; Nian-Ping FENG ; Ying LIU
China Journal of Chinese Materia Medica 2023;48(9):2419-2425
This study combined the herbal pair Platycodonis Radix-Curcumae Rhizoma(PR-CR) possessing an inhibitory effect on tumor cell proliferation and metastasis with the active component of traditional Chinese medicine(TCM) silibinin-loaded nanoparticles(NPs) with a regulatory effect on tumor microenvironment based on the joint effect on tumor cells and tumor microenvironment to inhi-bit cell metastasis. The effects of PR-CR on the cellular uptake of NPs and in vitro inhibition against breast cancer proliferation and metastasis were investigated to provide an experimental basis for improving nanoparticle absorption and enhancing therapeutic effects. Silibinin-loaded lipid-polymer nanoparticles(LPNs) were prepared by the nanoprecipitation method and characterized by transmission electron microscopy. The NPs were spherical or quasi-spherical in shape with obvious core-shell structure. The mean particle size was 107.4 nm, Zeta potential was-27.53 mV. The cellular uptake assay was performed by in vitro Caco-2/E12 coculture cell model and confocal laser scanning microscopy(CLSM), and the results indicated that PR-CR could promote the uptake of NPs. Further, in situ intestinal absorption assay by the CLSM vertical scanning approach showed that PR-CR could promote the absorption of NPs in the enterocytes of mice. The inhibitory effect of NPs on the proliferation and migration of 4T1 cells was analyzed using 4T1 breast cancer cells and co-cultured 4T1/WML2 cells, respectively. The results of the CCK8 assay showed that PR-CR-containing NPs could enhance the inhibition against the proliferation of 4T1 breast cancer cells. The wound healing assay indicated that PR-CR-containing NPs enhanced the inhibition against the migration of 4T1 breast cancer cells. This study enriches the research on oral absorption of TCM NPs and also provides a new idea for utilizing the advantages of TCM to inhibit breast cancer metastasis.
Humans
;
Mice
;
Animals
;
Female
;
Silybin/therapeutic use*
;
Caco-2 Cells
;
Polymers/chemistry*
;
Nanoparticles/chemistry*
;
Cell Line, Tumor
;
Breast Neoplasms/pathology*
;
Tumor Microenvironment
5.Protective effect of silibinin on islet β cells in C57BL/6J mice fed a highfat diet.
Ke CHEN ; Jun XU ; Honghui HE ; Liling ZHAO ; Jing XIONG ; Zhaohui MO
Journal of Central South University(Medical Sciences) 2015;40(2):165-170
OBJECTIVE:
To explore the eff ect of silibinin on β cells in C57BL/6J mice fed a high-fat diet and the possible mechanisms.
METHODS:
A total of 18 male C57BL/6J mice at 3 weeks old were divided into a normal chow group (n=6), a high-fat diet group (n=6) and a high-fat diet plus silibinin group (n=6). Aft er intervention for 10 weeks, fasting blood glucose (FBG), fasting insulin (FINS), triglycerides (TG), alanine aminotransferase (ALT), creatinine (Cr) and blood urea nitrogen (BUN), lipid metabolism, antioxidant enzyme activities and apoptosis were evaluated. Pancreatic tissues were isolated to examine insulin-induced gene-1 (Insig-1), sterol regulatory element binding protein-1c (SREBP-1c) and fatty acid synthetase (FAS) mRNA and protein expression.
RESULTS:
Compared with the high-fat diet group, the function of insulin secretion was improved, and the level of blood glucose was decreased in the high-fat diet plus silibinin group (P<0.05). The levels of lipid content and oxidative stress and the rates of β cell apoptosis were lower in high-fat diet plus silibinin group than those in the high-fat diet group (both P<0.05). Simultaneously, the silibinin could promote the expression of Insig-1 and depress the expression of SREBP-1c and FAS (all P<0.05). Moreover, there was no significant difference in the levels of serum ALT, Cr and BUN among the 3 groups (all P>0.05).
CONCLUSION
Silibinin can protect β cells of mice fed a high-fat diet, and this effect might be related to, at least partially, increase in its antioxidative ability through regulation of insig-1/SREBP-1c pathway. Moreover, silibinin is safe for long-term treatment.
Alanine Transaminase
;
blood
;
Animals
;
Apoptosis
;
Blood Glucose
;
analysis
;
Blood Urea Nitrogen
;
Creatinine
;
blood
;
Diet, High-Fat
;
Fatty Acid Synthases
;
metabolism
;
Insulin
;
blood
;
Insulin-Secreting Cells
;
cytology
;
drug effects
;
Lipid Metabolism
;
Lipids
;
Male
;
Membrane Proteins
;
metabolism
;
Mice
;
Mice, Inbred C57BL
;
Oxidative Stress
;
Silybin
;
Silymarin
;
pharmacology
;
Sterol Regulatory Element Binding Protein 1
;
metabolism
;
Triglycerides
;
blood
6.Reversing effects of silybin on TAA-induced hepatic CYP3A dysfunction through PXR regulation.
Yuan XIE ; Hai-Ping HAO ; Hong WANG ; Zhao-Xian WANG ; Guang-Ji WANG
Chinese Journal of Natural Medicines (English Ed.) 2013;11(6):645-652
AIM:
Silybin (SB), a major constituent of the milk thistle, has been used to treat several liver disorders. However, liver diseases were always accompanied by CYP450 dysfunction. This study was designed to explore the relationship between the hepatoprotective effect and CYP3A regulation of SB during thioacetamide (TAA)-induced rat liver injury.
METHODS:
Serum biochemical analysis and histopathological study were taken to evaluate the hepatoprotectinve effect of SB. α-SMA were detected by immunohistochemical analysis and cytokine release in rat liver was determined by ELISA assay. CYP3A and PXR expression were determined by RT-PCR and Western blot analysis, and CYP3A activity was based on the midazolam 4-hydroxylation reaction. Also, siRNA transfection was induced in HepG2 cells to evaluate the effect of PXR on cytotoxicity and CYP3A4 dysregulation caused by TAA.
RESULTS:
SB showed powerful hepatoprotective effects, and anti-inflammatory and anti-fibrosis effects, and reversed the loss of CYP3A and PXR in TAA-injured rat liver, and decreased PXR translocation into the cell nucleus. PXR silencing weakened the effect of SB on cytoprotection and CYP3A regulation.
CONCLUSIONS
PXR was a very important factor of CYP3A regulation and might be the target of SB in TAA-induced liver disease. Also, because of the potential interactions of SB and co-administered medicines, it might be necessary to adjust the dosage in the clinical medication of liver disease.
Animals
;
Chemical and Drug Induced Liver Injury
;
drug therapy
;
enzymology
;
Cytochrome P-450 CYP3A
;
genetics
;
metabolism
;
Drugs, Chinese Herbal
;
administration & dosage
;
Liver
;
drug effects
;
enzymology
;
metabolism
;
Male
;
Milk Thistle
;
chemistry
;
Pregnane X Receptor
;
Rats
;
Rats, Sprague-Dawley
;
Receptors, Steroid
;
genetics
;
metabolism
;
Signal Transduction
;
drug effects
;
Silybin
;
Silymarin
;
administration & dosage
;
Thioacetamide
;
adverse effects